[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357738-105":59,"doc-detail-357738-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","combination-therapy-with-hsp90-inhibitors-and-nanopulse-stimulation-synergistically-impedes-hepatocellular-carcinoma-and-breast-cancer-growth-in-mice","Combination therapy with HSP90 inhibitors and NanoPulse stimulation synergistically impedes hepatocellular carcinoma and breast cancer growth in mice","","Nanoscale NanoPulse Stimulation (NPS) and Heat Shock Protein 90 (HSP90) inhibitors are combined to suppress hepatocellular carcinoma (HCC) and breast cancer growth in mouse models. Results show that NPS plus HSP90 inhibitors reduce tumor growth beyond the additive effects of either treatment alone. The synergy promotes cell death via DNA damage, PARP activation, and caspase-3-mediated apoptosis, while allowing lower inhibitor and stimulation doses to reach comparable outcomes and potentially reduce side-effect risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/combination-therapy-with-hsp90-inhibitors-and-nanopulse-stimulation-synergistically-impedes-hepatocellular-carcinoma-and-breast-cancer-growth-in-mice/357738/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/combination-therapy-with-hsp90-inhibitors-and-nanopulse-stimulation-synergistically-impedes-hepatocellular-carcinoma-and-breast-cancer-growth-in-mice/357738.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatments are combined in this study?","Question",{"text":112,"@type":113},"The study combines two HSP90 inhibitors (AUY-922 or 17-AAG) with NanoPulse Stimulation (NPS).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is synergy between NPS and HSP90 inhibitors demonstrated?",{"text":117,"@type":113},"The combination reduces tumor growth more than the sum of effects from each treatment given alone, indicating a synergistic effect.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological mechanisms drive the combined anti-tumor effect?",{"text":121,"@type":113},"The combination promotes apoptosis through DNA damage, PARP activation, and caspase-3-mediated apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357738,1790194149,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCombination therapy with HSP90 inhibitors and NanoPulse stimulation synergistically impedes hepatocellular carcinoma and breast cancer growth in mice  \nChristiana Dimitropoulou1, GaganThangjam1, Brittany P. Lassiter1, Teresa Hooker1, Ruben M. L. Colunga Biancatelli1,2􀀍, John D. Catravas1,3,4 & Stephen J. Beebe1,4  \nNanopulse Stimulation (NPS) represents a promising and innovative therapeutic approach to cancer. Heat shock protein 90 Inhibitors (HI), on the other hand, are currently under investigation in multidrug chemotherapy trials for various types of malignancies. Here we present results of a combination therapy employing two HSP90 inhibitors (AUY-922 or 17-AAG) and NPSto ablate cancer growth. We firstly tested the inhibitors alone or in combination with NPS in vitro in N1S1 cells, and then into two models of orthotopic Hepatocellular Carcinoma (HCC) and 4T1-Luc breast cancer. NPS + HI reduced tumor growth more than the sum of HI and NPS administered alone, promoting cell death through DNA-damage, PARP activation and caspase-3-mediated apoptosis. Furthermore, HI and NPS, when combined, were used in lower doses than those required to achieve similar results, thus reducing the risk of potential side effects. By acting synergistically, combination therapy with HSP90 Inhibitors and NanoPulse Stimulation acts through distinct mechanisms, demonstrating a potent treatment that results in synergistic tumor mass reduction.  \nKeywords Anti-cancer, NanoPulse stimulation, NPS, nsPEF, Heat shock protein, HSP90 inhibitor, AUY-922, Multi-drug approach  \nHepatocellular carcinoma (HCC) and triple-negative breast cancer (TNBC) exemplify solid malignancies for which current therapeutic options remain inadequate. HCC is the sixth most common cancer worldwide and the third leading cause of cancer-related death; fewer than 20% of patients are candidates for curative resection or transplantation at diagnosis, and systemic therapies — including multi-kinase inhibitors and immune checkpoint inhibitors—provide modest survival benefit in advanced disease1,2. TNBC, which lacks targetable hormone receptors and HER2 amplification, carries the worst prognosis among breast cancer subtypes despite recent advances in immunotherapy and antibody-drug conjugates3. In both diseases, locoregional therapies (radiofrequency ablation, transarterial chemoembolization, cryotherapy) can achieve local tumor control but are limited by incomplete ablation margins, recurrence, and the inability to address systemic micrometastatic disease4,5. There is therefore a strong rationale for combining locoregional tumor destruction with systemic agents that exploit the unique biological vulnerabilities created by focal therapy. NanoPulse Stimulation (NPS; also referred to as nanosecond pulsed electric fields, nsPEFs, or nanosecond electric pulses, nsEPs) is abiophysical technique in which ultrashort, high-intensity electric fields that last on the order of billionths of a second (1/1 × 109 s), are applied to cells and tissues6,7. The translation of pulsed-power physics into biological systems provides a stimulus that does not naturally exist in living organisms; as a consequence, NPS elicits unique bioelectric and biochemical responses that have not been shaped by evolutionary adaptation. Unlike conventional electroporation, the electric fields generated by NPS penetrate through cells rather than traveling  \n1Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA 23508, USA. 2Division of Pulmonary and Critical Care, Department of Internal Medicine, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA, USA. 3School of Medical Diagnostic and Translational Sciences, Ellmer College of Health Sciences, Old Dominion University, Norfolk, VA, USA. 4John D. Catravas and Stephen J. Beebe contributed equally to this work. 􀀍 email: [rcolunga@odu.edu](rcol","cbCainoUbb9ufrCM","https://ap.wps.com/l/cbCainoUbb9ufrCM","pdf",4461397,14,"English","# Abstract and study rationale\n## In vitro testing in N1S1 cells\n## In vivo orthotopic tumor models\n## Mechanisms of synergistic tumor suppression\n## Clinical relevance and limitations of current therapies\n## Background on NanoPulse Stimulation (NPS)\n## Background on HSP90 and HSP90 inhibitors","[{\"question\":\"What treatments are combined in this study?\",\"answer\":\"The study combines two HSP90 inhibitors (AUY-922 or 17-AAG) with NanoPulse Stimulation (NPS).\"},{\"question\":\"How is synergy between NPS and HSP90 inhibitors demonstrated?\",\"answer\":\"The combination reduces tumor growth more than the sum of effects from each treatment given alone, indicating a synergistic effect.\"},{\"question\":\"What biological mechanisms drive the combined anti-tumor effect?\",\"answer\":\"The combination promotes apoptosis through DNA damage, PARP activation, and caspase-3-mediated apoptosis.\"}]","Combination therapy with HSP90 inhibitors and NanoPulse stimulation synergistically impedes hepatocellular carcinoma and breast cancer growth in mice | PDF",1790131596,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ffdf01b6a31424b9bea731d2b3c184d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47536395ccf35633123d765f911007c9.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b551e7d48be4ebff066bfb96e3d167a6.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4dfdb36c4e74e6184d677e759143ba0.webp",980,1287]